Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Crit Rev Immunol ; 32(4): 321-34, 2012.
Article in English | MEDLINE | ID: mdl-23237508

ABSTRACT

Since the discovery of the myc gene, few genes are likely to have such influence on biomedical research. The diversity of the biological functions regulated by this transcription factor and its impact in human health have attracted investigators from many different fields. The development of conditional knockout mouse models has allowed for the characterization of Myc-driven molecular mechanisms in primary cells in physiological and pathological conditions. In this review, we discuss some of the main functions and recent findings regarding c-Myc in in vivo B lymphocyte differentiation from early progenitors to terminally differentiated cells.


Subject(s)
B-Lymphocytes/cytology , B-Lymphocytes/metabolism , Cell Differentiation , Proto-Oncogene Proteins c-myc/metabolism , Animals , Humans , Proto-Oncogene Mas , Proto-Oncogene Proteins c-myc/deficiency , Proto-Oncogene Proteins c-myc/genetics
2.
Oncogene ; 21(46): 7131-6, 2002 Oct 10.
Article in English | MEDLINE | ID: mdl-12370836

ABSTRACT

In order to investigate the molecular mechanisms implicated in the induction of chemo sensitivity by adenovirus E1a gene expression, we decided to investigate which signal transduction pathways could be affected by the E1a gene in Human Normal Fibroblast (IMR90). No effect was observed in SAPK pathways (p38MAPK and JNK), but E1a was able to affect the Akt activation mediated by insulin. This result was confirmed by transient transfection experiments performed in Cos-7 cells and also observed in other transformed cell lines such as A431. Furthermore, E1a expression induces a decrease in the basal status of Akt activity. Finally we demonstrated that E1a is able to block the Akt activation mediated by cisplatin and correlates with a sensitive phenotype. In summary, our data demonstrate that specific inhibition of the PI3K/Akt pathway mediates some of the biological properties of E1a such as induction of chemosensitivity.


Subject(s)
Adenovirus E1A Proteins/genetics , Antineoplastic Agents/pharmacology , Cisplatin/pharmacology , Phosphatidylinositol 3-Kinases/physiology , Protein Serine-Threonine Kinases , Proto-Oncogene Proteins/physiology , Signal Transduction , Animals , COS Cells , DNA Damage , Drug Resistance, Neoplasm , Genes, ras , Humans , Insulin/pharmacology , Phosphorylation , Proto-Oncogene Proteins c-akt
3.
Oncogene ; 21(6): 974-9, 2002 Jan 31.
Article in English | MEDLINE | ID: mdl-11840343

ABSTRACT

p73 is a novel member of the p53 family of tumor suppressor proteins which is involved in cellular differentiation, tumor suppression, and the response to genotoxic stress. The molecular mechanisms regulating p73 activity are still poorly understood. Recently, p73 was found to be a target of the enzymatic activity of c-Abl, a non-receptor tyrosine kinase that potently activated in response to DNA damage. Here, we present evidence that c-Abl induces the phosphorylation of p73 in threonine residues adjacent to prolines, and that the p38 MAP kinase pathway mediates this response. Furthermore, we found that activation of p38 is sufficient to enhance the stability of p73, and that the transcriptional activation of p73 by c-Abl requires the activity of p38. These findings indicate that members of the MAP kinases superfamily of signaling molecules can regulate p73, and support a role for the p38 MAP kinase in a novel biochemical pathway by which c-Abl regulates this p53-related molecule.


Subject(s)
DNA-Binding Proteins/metabolism , Genes, abl , MAP Kinase Signaling System , Mitogen-Activated Protein Kinases/physiology , Nuclear Proteins/metabolism , Protein Processing, Post-Translational/physiology , Proto-Oncogene Proteins c-abl/physiology , Bone Neoplasms/pathology , Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Cell Line , DNA-Binding Proteins/genetics , Enzyme Activation , Enzyme Inhibitors/pharmacology , Epithelial Cells/metabolism , Genes, Tumor Suppressor , Humans , Imidazoles/pharmacology , JNK Mitogen-Activated Protein Kinases , Kidney , MAP Kinase Kinase 1 , MAP Kinase Kinase 6 , MAP Kinase Kinase 7 , Mitogen-Activated Protein Kinase Kinases/metabolism , Mitogen-Activated Protein Kinases/antagonists & inhibitors , Mitogen-Activated Protein Kinases/metabolism , Multigene Family , Nuclear Proteins/genetics , Osteosarcoma/pathology , Phosphorylation , Phosphoserine/metabolism , Phosphotyrosine/metabolism , Proline/chemistry , Protein Processing, Post-Translational/genetics , Protein Serine-Threonine Kinases/metabolism , Protein-Tyrosine Kinases/metabolism , Pyridines/pharmacology , Recombinant Fusion Proteins/physiology , Transcription, Genetic , Transfection , Tumor Cells, Cultured , Tumor Protein p73 , Tumor Suppressor Proteins , p38 Mitogen-Activated Protein Kinases , src Homology Domains
SELECTION OF CITATIONS
SEARCH DETAIL
...